학술논문
Impact of the First Wave of the COVID-19 Pandemic on the Lyon University Hospital Cancer Institute (IC-HCL)
Document Type
article
Author
Anne-Sophie Belmont; Christophe Sajous; Amandine Bruyas; Sara Calattini; Stéphanie Cartalat; Marion Chauvenet; Marc Colombel; Stéphane Dalle; Tristan Dagonneau; Marie Darrason; Gilles Devouassoux; Michaël Duruisseaux; Marielle Guillet; Olivier Glehen; Pierre Philouze; François Tronc; Thomas Walter; Benoît You; Gilles Freyer
Source
Cancers, Vol 14, Iss 1, p 29 (2021)
Subject
Language
English
ISSN
2072-6694
Abstract
This article presents the protective measures put in place at the “Institut de Cancérologie des Hospices de Lyon” (IC-HCL) during the first wave of the COVID-19 pandemic in France (spring 2020) and how they impacted IC-HCL clinical activity. Spring 2020 activities were compared to winter 2019–2020. Results showed a decrease of activity of 9% for treatment dispensations, 17% for multidisciplinary team meetings, 20% for head and neck and thoracic surgeries, and 58% for new patient enrolment in clinical trials. Characteristics of patients treated for solid cancer and hospitalized for COVID-19 during spring 2020 were collected in a retrospective study. Mortality was attributed to COVID-19 for half of the cases, 82% being patients above 70 and 73% being stage IV. This is in concordance with current findings concluding that the risk of developing severe or critical symptoms of COVID-19 is correlated with factors co-occurring in cancer patients and not to the cancer condition per se. While a number of routines and treatment regimens were changed, there was no major decline in numbers of treatments conducted at the IC-HCL during the first wave of the COVID-19 pandemic that hit France between March and May 2020, except for clinical trials and some surgery activities.